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Introduction. Tuberous sclerosis (TS) is the leading cause of genetic epilepsy worldwide. Here, we evaluate changes in seizure
outcomes following resective epilepsy surgery in children with TS over time. Methods. A systematic review of the literature was
performed to identify studies reporting seizure outcomes following resective epilepsy surgery in children with TS. Using an
individual participant meta-analysis approach, seizure outcomes and associated covariates were combined. Multivariate logistic
regression was used to determine significant associations between seizure outcomes and time of surgery. Results. Twenty studies
from 1966 to present, yielding 186 participants, met the inclusion criteria for the study. On univariate analysis, there was a
significant improvement in seizure outcomes in children who underwent resective epilepsy surgery within the last 15 years
compared to older cohorts (chi-square 4.1; P = 0.043). On multivariate analysis, adjusting for length of followup, this trend
was not significant (OR 0.52; 95% CI 0.23–1.17; P = 0.11). In the last 15 years, a greater proportion of younger children aslo
underwent resective surgery compared to older cohorts (OR 0.93; 95% CI 0.89–0.97; P < 0.01). Conclusions. A trend towards
improved seizure outcomes following resective surgery for TS was observed from 1966 to present on multivariate analysis.
1. Introduction
Tuberous sclerosis complex (TS) is the leading cause of
genetic childhood epilepsy worldwide [1]. The condition is
characterized by inactivating mutations in TSC1, encoding
hamartin, or TSC2, encoding tuberin [1]. These lead to
downstream hyperactivation of the mammalian target of
rapamycin (mTOR) pathway and associated kinase signalling
cascades, resulting in abnormal cortical development and
epilepsy in the majority of affected children. The neurolog-
ical manifestations of TS are associated with considerable
morbidity [2]. Specifically, 50–80% of children with epilepsy
secondary to TS may be refractory to medical treatment [3,
4]. Furthermore, seizure frequency and epilepsy severity have
been previously related to the extent of cognitive impairment
in children with TS [5].
Resective surgical strategies are increasingly utilized in
children with TS due to the medical and psychosocial burden
of medically intractable epilepsy. Surgical treatment has been
shown to result in a significant control of epilepsy and
improvements in the quality of life of children with TS
[6]. These surgical strategies have, however, changed drama-
tically over the last several decades. This is largely due to
advances in localization strategies, which are particularly
important in TS, as multiple tubers are often present and
differentiating the epileptogenic tuber from others can be
challenging. Standard localization modalities for the identi-
fication of epileptogenic cortex in TS may include magnetic
resonance imaging (MRI), scalp and intracranial electroen-
cephalography (EEG), positron emission tomography (PET),
magnetoencephalography (MEG), and single-photon emis-
sion computed tomography (SPECT).
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The last 15 years (1996–2011) specifically have also seen
numerous advancements in noninvasive and invasive meth-
ods for the localization of eloquent cortex, allowing for
more effective and safer surgical treatments of epilepsy. These
include advances in the aforementioned technologies and the
addition of functional MRI, diffusion tensor imaging-fiber
tractography, and diffusion-weighted imaging. During this
time period, there have also been considerable refinement
of techniques and a reliance on the concordance of multiple
localization modalities to guide surgical strategies. It is
unclear, however, whether advances in technology have had
a significant impact on seizure outcomes in children with
TS. The current paper utilizes independent participant data
meta-analysis methodology to determine whether seizure
outcomes have improved over the last 50 years following
resective surgery for children with TS.
2. Methods
A systematic review of literature was performed to identify
studies reporting seizure outcomes in children with medi-
cally intractable epilepsy over the last 50 years. The following
electronic databases were searched for relevant articles with
no date or language restrictions: MEDLINE, EMBASE,
CINAHL, and Web of Science. The search was performed
in October 2011. The search strategy was limited to humans
and incorporated the following terms: “tuberous sclerosis,”
“epilepsy surgery,” “seizure outcomes,” “Engel classification,”
and “predictors.” The inclusion criteria for studies were (1)
case-controlled or cohort studies; (2) consecutive partici-
pants; (3) at least 90% of participants be under the age
of 19 at time of surgery; (4) at least 90% of subjects have
TS; (5) at least 90% of subjects have undergone resective
epilepsy surgery; and (6) seizure outcomes are reported. We
chose high thresholds (i.e., 90%) for inclusion in the meta-
analysis to ensure that the data was not biased by child-
ren with other pathologies or those who did not undergo
a resective surgical procedure. Additionally, case reports,
reviews, mixed studies (adults and children), and studies
including children who have undergone previous resective or
palliative (i.e., corpus callosotomy, multiple subpial transec-
tion, vagal nerve stimulator insertion) surgery were excluded.
Title and abstract screening as well as full text review were
performed independently and in duplicate. Disagreements
between reviewers were resolved by joint review and consen-
sus with respect to the eligibility criteria.
An independent participant datameta-analysis (IPDMA)
approach was utilized whereby the raw participant-level data
were obtained from each study and synthesized. The primary
outcome of interest was whether seizure outcomes improved
in published studies over time. Specifically, individual par-
ticipants were dichotomized based on their date of surgery
(defined for each participant by subtracting their individual
length of followup from the year of article participation) into
recent cohorts (surgery within the last 15 years) and older
cohorts (surgery greater than 15 years ago). Differences in
seizure outcome were compared between the two cohorts.
Seizure outcome was defined as satisfactory (Engel I-II) and
unsatisfactory (Engel III-IV) at the last followup.
Data are presented as frequencies or means with standard
deviations. The chi-squared test was employed for univari-
ate analysis to determine differences in seizure outcomes
between recent and older cohorts. Multivariate logistic
regression was used to adjust for the length of followup, as
those with longer follow-up times may be more likely to have
recurrence of seizure and therefore a worse Engel score. A P
value less than 0.05 was accepted as statistically significant.
All data were analyzed using SAS statistical software 9.3
(Cary, NC, USA).
3. Results
We identified 9863 citations from the electronic database
queries, of which 241 full text articles were reviewed.
Twenty articles reporting on 181 participants were ultimately
included in the study (Table 1). The subjects’ demographics
are presented in Table 2. The mean age of children was 9.8 ±
8.8 years. Thirteen articles (65%) originated from North
America, while five (25%) and three (15%) originated from
Europe and Asia, respectively. One hundred and twenty-six
(70%) of these subjects had a satisfactory seizure outcome
with a mean duration of followup of 2.3 years. The majority
of studies performed a surgical strategy involving tuberec-
tomy or lobectomy (70%); however, several studies also
included multilobar resections (50%) and hemispherectomy
(10%).
Using an IPDMA approach, the surgical outcomes of par-
ticipants were concatenated and dichotomized as favourable
(Engel I-II) and unfavourable (Engel III-IV) and compared
in recent and older cohorts. On univariate analysis, recent
cohorts of children undergoing resective procedures (within
the last 15 years) were significantly more likely to achieve
a favourable outcome compared to older cohorts (older
cohorts to 15 years ago; chi-squared = 4.1; P = 0.04;
Figure 1). Multivariate logistic regression was applied to
determine differences in seizure outcomes between the two
time cohorts, while adjusting for each participant’s duration
of following. There was a trend towards better seizure out-
comes in recent cohorts following adjusting for duration of
followup, which did not reach the threshold for statistical
significance (odds ratio (OR) 0.52; 95% confidence interval
(CI) 0.23–1.17; P = 0.11).
When the epoch of surgery was entered into the logistic
regression model as the dependent variable, it was also
determined that the age of children at the time of surgery was
significantly different between the two epochs. Over the last
15 years, a greater proportion of younger children underwent
a resective surgery compared to older cohorts (OR 0.93; 95%
CI 0.89–0.97; P < 0.01). There were no significant differences
between outcomes in North America and elsewhere (P =
0.45).
4. Discussion
This exploratory analysis determined that there was a non-
significant trend on multivariate analysis towards improved
seizure outcomes over the last 15 years in children with
medically intractable epilepsy secondary to TS following
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Table 1: Included studies of outcomes following resective surgery in children with tuberous sclerosis and intractable epilepsy.
First author
(reference)
Year of publication Country of origin Number of subjects Percentage seizure-free
Perot [21] 1966 Canada 7 43
Bebin [22] 1993 USA 7 71
Avellino [23] 1997 USA 9 50
Baumgartner [24] 1997 USA 4 25
Guerreiro [25] 1998 Canada 12 67
Asano [26] 2000 USA 7 71
Koh [27] 2000 USA 13 73
Karenfort [5] 2002 Germany 8 88
Kagawa [28] 2005 USA 17 71
Lachhwani [29] 2005 USA 17 71
Jansen [3] 2006 Netherlands 3 67
Kamimura [30] 2006 Japan 3 100
Weiner [31] 2006 USA 25 92
Jansen [32] 2007 Netherlands 6 67
Teutonico [33] 2008 Italy/USA 11 45
Major [34] 2009 USA 3 67
Wen [35] 2009 China 4 75
van der Heide [36] 2010 Netherlands 6 67
Liang [37] 2010 China 17 76































Figure 1: Proportion of children with tuberous sclerosis achieving
favourable seizure outcome (Engel I-II) following resection surgery
in recent and older cohorts. Recent cohorts demonstrate signifi-
cantly improved seizure outcomes on univariate analysis.
resective surgery. Furthermore, we find that compared to
older cohorts, more recent cohorts included children with a
younger mean age. The current analysis is the largest study
evaluating trends in seizure outcome in TS, concatenating
data from seven countries and three continents using an











Percentages expressed as a proportion of studies employing the surgical
strategies.
IPDMA approach. These findings should inform the acade-
mic community regarding advances in the surgical treatment
of children with TS over the last 50 years.
The last 15 years have seen numerous advances in diag-
nostic imaging and localization modalities. For instance, it
is well described that tubers may be conspicuous on T2-
weighted and FLAIR MRI sequences; however, it has been
recently reported that epileptic tubers demonstrate increased
apparent diffusion coefficients and tensor properties [7,
8]. Additionally, the evolution of MEG techniques, espe-
cially the coregistration of MEG dipoles with MRI, has
resulted in improved seizure outcomes in individual studies
[3]. Furthermore, novel markers have been developed to
identify the epileptic tuber, including alpha-[11C]-methyl-l-
tryptophan (AMT) PET, on the basis of findings of increased
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concentrations of serotonin and serotonin-immunoreactive
processes in epileptic cortex [9]. Finally, there has also been a
concerted effort to amalgamate numerous localization mod-
alities to the localization of the epileptogenic tuber. For
example, PET/MRI coregistration has been reported by some
groups to result in improved seizure outcomes [10]. Increas-
ingly, centres are relying upon the concordance of numerous
modalities in the surgical decision-making processes.
While there was a significant difference in seizure out-
comes between recent and older surgical cohorts on univari-
ate analysis, this trend did not reach statistical significance on
multivariate modelling. There may be several explanations
for this finding. Firstly, although advancements in technolo-
gies and surgical techniques have been achieved over the
last 15 years, there remains a significant heterogeneity in
their application to the presurgical evaluation of children
with epilepsy [11, 12]. Our results represent a global average
based on the concatenation of results from 20 published
series. The finding of a trend towards improved seizure
outcomes is therefore in and of itself highly encouraging.
Secondly, our dichotomization cutoff of 15 years was largely
based on the timing of the widespread introduction of
novel localization technologies to presurgical evaluation of
medically intractable epilepsy. It is possible that a time
lag in the application of these innovations or a “learning-
curve” at centres that have adapted these technologies may
delay improvements in surgical outcomes [13, 14]. Thirdly,
the widespread adoption of invasive monitoring by com-
prehensive epilepsy centres has permitted the treatment of
more complex patients that would have previously been
excluded from standard treatments such as lesionectomies
(tubectomies) [15]. It is possible that the lack of a significant
improvement is a reflection of the increasing complexity
of surgically treated TS made possible by advancements in
invasive monitoring technology. Finally, TS is a challenging
condition, whereby nonresected tubers may become inde-
pendently epileptogenic. The finding that seizure outcomes
between recent and older cohorts were not significant upon
statistical adjustment for length of followup may reflect the
phenomenon that children with TS often develop secondary
epilepsy syndromes on prolonged followup.
In the contemporary practice of pediatric epilepsy sur-
gery, there has also been a greater appreciation of the detri-
mental effects of seizures on childhood development [16, 17].
Furthermore, a longer duration of epilepsy is associated with
a lesser likelihood of seizure freedom; therefore, early surgical
intervention in young patient cohorts has been advocated by
numerous groups [18–20]. Indeed, it has been shown that
surgical treatment improves the quality of life of children
with TS and that, given the choice, the vast majority (94%)
of parents would choose to undergo the resective procedure
once again [6]. The current finding of significantly younger
children undergoing resective procedures in the more recent
cohort suggests that there have been improvements in the
triage, referral, and presurgical workup of younger children
with intractable epilepsy. This of course may also contribute
to the trend in improvements in seizure outcomes observed.
The most important limitation of the current article is
the possibility that appropriate manuscripts were missed in
the systematic review search strategy. Secondly, because we
rely on the variables collected by the authors of the original
articles, we were unable to include additional potential cov-
ariates in the multivariate regression model. Furthermore,
there were considerably fewer children in the older cohort
compared to the more recent cohort. Finally, as these data are
based on retrospective series, several biases inherent to such
methodologies may also limit the findings presented herein.
A significant strength of the current methodology is the use
of the IPDMA approach to concatenate individual parti-
cipant data from the selected articles, thereby bypassing
numerous publication biases.
5. Conclusions
Compared to older cohorts, children that have undergone
resective surgery for medically intractable epilepsy secondary
to tuberous sclerosis in the past 15 years demonstrate
improved seizure outcomes on univariate, but not multivari-
ate analysis. A greater proportion of younger children was
also included in the recent cohort. This study hopes to
inform the academic community regarding advancements in
the surgical treatment of TS over time. Further research and
policy are necessary to improve seizure outcomes and subse-
quent analyses should reexamine the effects of such advance-
ments on future patient populations.
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